Current Edition

IN PURSUIT
Editorial Archive

In Pursuit of eConsent: Best Practice Recommendations for Successful Integration

Electronic informed consent (eConsent) solutions have been introduced in recent years, representing a major advancement in improving information delivery to study participants in clinical research. …

Continue Reading →
CARCINOMA
Editorial Archive

Clinical Development in Challenging Cancers: Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare cancer with an estimated incidence of 1 to 2 patients per million people annually. About 50%–70% of adrenal cancers …

Continue Reading →
PEDIATRIC
Editorial Archive

Companies Need More Awareness of EU Pediatric Investigation Plans (PIPs)

Pediatric legislation was introduced based on the American Academy of Pediatrics (AAP) concerns that children did not participate sufficiently in therapeutic progress. But child healthcare …

Continue Reading →
BRAIN
Editorial Archive

Constructing Composites to Optimise Cognitive Outcomes

Henry J. Riordan, Ph.D., Executive Vice President of Medical and Scientific Affairs and Global Lead for Neuroscience at Worldwide Clinical Trials, shares his views on …

Continue Reading →
C.TRIAL CEE
Editorial Archive

Clinical Trials in Central and Eastern Europe: Keeping Up with Global Competition

A great number of willing patients, highly experienced researchers and EMA-compliant legislation make the CEE region an attractive research site destination. The data at large …

Continue Reading →
CHINA pic
Editorial Archive

Clinical Trial Enrolment in China: The Potential Role of Patient Advocacy Groups and Digital Health Networks

China has a large and vibrant ecosystem of patient advocacy groups and digital health networks that provides clinical trial sponsors with opportunities to engage and …

Continue Reading →
RISK MANAGEMENT
Editorial Archive

Risk-based Monitoring: The Innovative Model Redefining Clinical Trial Risk Management

One area in the clinical trial process that has been identified for improvement is risk-based planning and management. Monitoring and managing risk has always been …

Continue Reading →
CDISC pic
Editorial Archive

CDISC for Non-Experts Everything You Always Wanted to Know About CDISC (But Were Afraid to Ask)

CDSIC is meant to enable you to collect, store and transfer clinical data in a way that makes them easily usable on a large scale …

Continue Reading →
DRUG DEVELOPMENT
Editorial Archive

The Challenges and Benefits of Biosimilar Drug Development for Trastuzumab, a Precision Medicine

Monoclonal antibodies (mAb) are among the most promising biologic drugs currently on the market for treatment of life-threatening diseases. The selectivity and specificity of these …

Continue Reading →
PHARMACOVIGILANCE
Editorial Archive

Pharmacovigilance’s Growing Influence

Pharmacovigilance will always be about protecting patients. The discipline is rapidly evolving into something greater than regulatory compliance; increasingly, pharmacovigilance has a central role to …

Continue Reading →